Breadcrumb

What’s new at The Institute?

New funding for cystic fibrosis research

Larry Lands, a senior scientist at The Institute, will lead a new project focusing on rare genetic mutations

Addressing health disparities through genomics

Researcher from The Institute co-leads $8.3 million genomics sequencing project to advance for Black communities

PAP therapy may improve cognitive function in Parkinson’s disease

Research highlights potential cognitive and symptom improvements in Parkinson’s patients through treatment of obstructive sleep apnea with...

Advancing Equity in Research

For Black History Month, patient partners, community actors, academics, and clinicians gathered at The Institute to address racism

New study reveals key mechanism behind natural resistance to tuberculosis

Researchers identify a unique immune response in the lungs that may help prevent tuberculosis infection...

Driving innovation in rare disease research: The Institute and RARE.Qc

New funding from Génome Québec will strengthen rare disease data infrastructure, accelerating research and discoveries

New global guideline on candidiasis features expertise from The Institute

Dr. Don Vinh, the only Canadian primary author, joins over 100 experts from 35 countries in this landmark effort

Engineered IL-2 molecule shows promise in treating autoimmune disease

Researchers from The Institute, in collaboration with Sanofi, develop a novel therapy to enhance immune regulation in...

D2R awards over $6 million to support Core Platforms

Three platforms at The Institute will benefit from new funding for innovation and sustainability

New discovery could help protect against influenza

Preclinical trial uncovers how beta-glucan, found in all fungi, can ‘reprogram’ immune cells to prevent lung inflammation

Learn more about the RI-MUHC